需申請審核

ACRIN-NSCLC-FDG-PET

Positron Emission Tomography Pre- and Post-treatment Assessment for Locally Advanced Non-small Cell Lung Carcinoma

This was a multicenter clinical trial by the ACRIN Cooperative Group (now part of ECOG-ACRIN) and the RTOG Cooperative Group (now part of NRG) using FDG-PET imaging both pre- and post-chemoradiotherapy.

The objective of the ACRIN 6668 multi-center clinical trial was to determine if the PET standardized uptake value (SUV) measurement from FDG-PET imaging shortly after treatment is a useful predictor of long-term clinical outcome (survival) after definitive chemoradiotherapy. Eligible patients were those older than 18 years with AJCC-criteria clinical stage IIB/III non-small cell lung carcinoma who were being planned for definitive concurrent chemoradiotherapy (inoperable disease).

Primary Aim Findings: Higher post-treatment tumor SUV (SUVpeak, SUVmax) is associated with worse survival in stage III NSCLC, although a clear SUV cutoff value for routine clinical use as a prognostic factor was uncertain [1]. Later analyses found that larger pre-treatment metabolic tumor volumes (MTVs) were associated with significantly worse overall survival [2]. Other secondary analyses found potentially predictive image texture biomarkers.

Study Design Summary: Patients received conventional concurrent platinum-based chemoradiotherapy without surgery; post-radiotherapy consolidation chemotherapy was allowed. A baseline whole-body FDG-PET scan was performed prior to therapy. A second post-treatment whole-body FDG-PET scan occurred approximately 14 weeks after radiotherapy (at least 4 weeks after adjuvant chemotherapy).

Pre-treatment FDG-PET scans were performed on ACRIN-qualified scanners. Post-treatment FDG-PET scans were required to be performed within 12–16 weeks after completion of therapy, using the same scanner as that used for the pre-treatment scans.

Acknowledgements

This shared data set was provided in collaboration with the American College of Radiology Core Lab. Many thanks are due to the ACRIN 6668 trial team, and all the patients participating in the study.

This study was supported by the ACRIN Cooperative Group (now part of ECOG-ACRIN) and the RTOG Cooperative Group (now part of NRG) which received funding from the National Cancer Institute through UO1 CA080098 and UO1 CA079778.

資料與資源

此資料集沒有資料

額外的資訊

欄位
最後更新 十二月 3, 2019, 14:28 (CST)
建立 二月 14, 2019, 10:19 (CST)

推薦資料集:


  • 澎湖縣七美鄉公所對鄉市民代表所提地方建設建議事項處理明細表

    付費方式 免費
    更新頻率 不定期
    七美鄉公所對鄉市民代表所提地方建設建議事項處理明細表
  • 107-108年度高雄市已公告徵收土地地籍資料

    付費方式 免費
    更新頻率 不定期
    高雄市107-108年度已公告徵收土地地籍資料
  • 水情監測歷史影像資料集 - 2019 東石鄉圍潭村站鏡頭

    付費方式 免費
    更新頻率 不定期
    本資料集彙整監測站 - 東石鄉圍潭村站鏡頭,2019年度每日歷史影像檔(.jpg)封裝之壓縮檔。檔名說明: 年度_月_日_測站名稱.zip 全台目前現有監測影像共有1089組監視影像歷史紀錄,監測重要河川、橋梁、堰壩等水利設施,以及易淹水地區,並全年不間斷監測並儲存資料。
  • 台灣中油股份有限公司_提供代收停車費加油站

    付費方式 免費
    更新頻率 不定期
    提供代收停車費服務之加油站
  • 國網洞見資料集_經濟_15

    付費方式 免費
    更新頻率 不定期
    關鍵字: 技術處,急難,郵政,存款,接管,合作社,指標,地震,銷售,淨值,等等